Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inogen (INGN) Capital Expenditures (2016 - 2022)

Inogen (INGN) has disclosed Capital Expenditures for 10 consecutive years, with -$2.3 million as the latest value for Q4 2022.

  • On a quarterly basis, Capital Expenditures fell 446.96% to -$2.3 million in Q4 2022 year-over-year; TTM through Dec 2022 was $428000.0, a 92.19% decrease, with the full-year FY2025 number at $2.5 million, up 1180.71% from a year prior.
  • Capital Expenditures was -$2.3 million for Q4 2022 at Inogen, down from $2.4 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $7.0 million in Q3 2018 to a low of -$2.3 million in Q4 2022.
  • A 5-year average of $920200.0 and a median of $278000.0 in 2019 define the central range for Capital Expenditures.
  • Peak YoY movement for Capital Expenditures: soared 14459.18% in 2018, then crashed 860.6% in 2020.
  • Inogen's Capital Expenditures stood at $803000.0 in 2018, then crashed by 375.09% to -$2.2 million in 2019, then surged by 297.06% to $4.4 million in 2020, then plummeted by 84.49% to $675000.0 in 2021, then plummeted by 446.96% to -$2.3 million in 2022.
  • Per Business Quant, the three most recent readings for INGN's Capital Expenditures are -$2.3 million (Q4 2022), $2.4 million (Q3 2022), and $254000.0 (Q2 2022).